Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12619001321134
Ethics application status
Approved
Date submitted
16/09/2019
Date registered
27/09/2019
Date last updated
8/09/2020
Date data sharing statement initially provided
27/09/2019
Date results provided
8/09/2020
Type of registration
Prospectively registered

Titles & IDs
Public title
Patient Experience of Multi Resistant Organism Care at QEII Jubilee Hospital
Scientific title
Patient Experience of Multi Resistant Organism Care at QEII Jubilee Hospital
Secondary ID [1] 299308 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
infectious diseases 314437 0
patient experience 314438 0
multi-resistant organisms 314439 0
Condition category
Condition code
Infection 312779 312779 0 0
Other infectious diseases

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
We will be doing cross-sectional patient surveys with informed consent. The aim of this project is to collate feedback from patients with Multi Resistant Organisms relating to the perception of their care while an inpatient at Queen Elizabeth II Jubilee Hospital. The findings will enable us to ascertain if the information currently provided is adequate and appropriate and delivered in a way that is meaningful and useable for the patients. This study will enable us to determine what/if any improvements that can made in our current management of patients with Multi Resistant Organisms.
A trained nurse from Infection Prevention and Management Service (IPMS) will invite patients to participate in an anonymous survey. Patients will be provided with information about the survey and allowed time to ask questions and if providing verbal consent, will be asked complete the survey. A patient survey consisting of 8 questions will be given to participants (6 multiple choice questions and 2 free text questions). Completion of the survey will take 5-10 minutes. The survey is completed once. There is no follow up required for this study. Patients can nominate to have a nurse from the Infection Prevention and Management Service come to talk to them should they have questions relating to their Multi-Resistant Organism infection.
Intervention code [1] 315577 0
Not applicable
Comparator / control treatment
None
Control group
Uncontrolled

Outcomes
Primary outcome [1] 321398 0
Satisfaction with hospital care during admission as an inpatient in an isolation room for Multi-Resistant Organism at QEII Jubilee Hospital, as assessed by study-specific questionnaire
Timepoint [1] 321398 0
Assessed once during inpatient hospital admission between October and December 2019.
Primary outcome [2] 321399 0
Patient level of understanding about isolation for Multi Resistant Organism infection at QEII Jubilee Hospital, as assessed by study-specific questionnaire.
Timepoint [2] 321399 0
Assessed once during inpatient hospital admission between October and December 2019.
Secondary outcome [1] 375251 0
Patient preference for information about Multi-Resistant Organism infection during hospital admission, as assessed by study-specific questionnaire.
Timepoint [1] 375251 0
Assessed once during inpatient hospital admission between October and December 2019.

Eligibility
Key inclusion criteria
Patients admitted to QEII Hospital and diagnosed with a Multi-Resistant Organism
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Patients who are Culturally and Linguistically Diverse (CALD) or cognitively impaired.

Study design
Purpose
Psychosocial
Duration
Cross-sectional
Selection
Defined population
Timing
Prospective
Statistical methods / analysis
Descriptive statistics (number, percentage) will be calculated.
Purposive sample of patients with a Multi Resistant Organism admitted over a 3 month period (or until 30 patients have participated)

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
1/10/2019
Actual
10/10/2019
Date of last participant enrolment
Anticipated
30/12/2019
Actual
22/11/2019
Date of last data collection
Anticipated
30/12/2019
Actual
22/11/2019
Sample size
Target
30
Accrual to date
Final
30
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 14801 0
Queen Elizabeth II Jubilee Hospital - Coopers Plains
Recruitment postcode(s) [1] 28051 0
4108 - Coopers Plains

Funding & Sponsors
Funding source category [1] 303829 0
Hospital
Name [1] 303829 0
Queen Elizabeth II Jubilee Hospital
Country [1] 303829 0
Australia
Primary sponsor type
Individual
Name
Dr Gillian Ray-Barruel
Address
Griffith University Nathan Campus, N48_0.09
170 Kessels Road
Nathan
QLD 4111
Country
Australia
Secondary sponsor category [1] 303956 0
None
Name [1] 303956 0
Address [1] 303956 0
Country [1] 303956 0
Other collaborator category [1] 280949 0
Individual
Name [1] 280949 0
Ms Tain Gardiner
Address [1] 280949 0
QEII Jubilee Hospital
Cnr Troughton and Kessels Roads
Coopers Plains, QLD 4108
Country [1] 280949 0
Australia
Other collaborator category [2] 280950 0
Individual
Name [2] 280950 0
Ms Alison Smith
Address [2] 280950 0
QEII Jubilee Hospital
Cnr Troughton and Kessels Roads
Coopers Plains QLD 4108
Country [2] 280950 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 304343 0
Metro South Health Service District Human Research Ethics Committee (EC00167)
Ethics committee address [1] 304343 0
Ethics committee country [1] 304343 0
Australia
Date submitted for ethics approval [1] 304343 0
10/09/2019
Approval date [1] 304343 0
02/10/2019
Ethics approval number [1] 304343 0
LNR/2019/QMS/57351
Ethics committee name [2] 304344 0
Griffith University HREC
Ethics committee address [2] 304344 0
Ethics committee country [2] 304344 0
Australia
Date submitted for ethics approval [2] 304344 0
16/09/2019
Approval date [2] 304344 0
10/10/2019
Ethics approval number [2] 304344 0
2019/824

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 96618 0
Dr Gillian Ray-Barruel
Address 96618 0
Griffith University Nathan Campus N48_0.09
170 Kessels Road
Nathan QLD 4111
Country 96618 0
Australia
Phone 96618 0
+61 07 3735 8442
Fax 96618 0
Email 96618 0
[email protected]
Contact person for public queries
Name 96619 0
Gillian Ray-Barruel
Address 96619 0
Griffith University Nathan Campus N48_0.09
170 Kessels Road
Nathan QLD 4111
Country 96619 0
Australia
Phone 96619 0
+61 07 3735 8442
Fax 96619 0
Email 96619 0
[email protected]
Contact person for scientific queries
Name 96620 0
Gillian Ray-Barruel
Address 96620 0
Griffith University Nathan Campus N48_0.09
170 Kessels Road
Nathan QLD 4111
Country 96620 0
Australia
Phone 96620 0
+61 07 3735 8442
Fax 96620 0
Email 96620 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment
Individual patient surveys will not be made public.
The findings will be collated, analysed for themes, and published in a peer-reviewed journal.


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.